Skip To The Main Content

New Drugs Need Agile Biomanufacturing


Last month, NNE’s Jeffery Odum offered his views on intelligent biomanufacturing and the factory of the future in the session, “Addressing Unique Challenges of Patient-Centric Supply Chain Needs,” March 21, at the 2018 PDA Annual Meeting in Orlando.

He took the time to answer a few questions about how innovative products, such as advanced therapy medicinal products (ATMPs), will affect pharmaceutical manufacturing for the PDA Letter.

You need to Login to view the full article. Please Login. Not a Member? Join today!

PDA Members Save Substantially